Envision Healthcare Corporation s trend and data analysis indicates that the stock price has dropped -2.2% in the past 12 Weeks but analyzing the 6 month chart of the stock, the price of the stock has managed to drop negative and it has dropped down to -4.7% . Looking at the past 52 week period, the stock price is down -9.3% . Relative price strength is a important factor used by wealth management firms while investing in stocks since the indicator compares the stock performance with the overall market. The relative price strength of Envision Healthcare Corporation has a negative value of -16.03 compared to overall market performance.Envision Healthcare Corporation is having a Relative Strength Index of 37.21 which indicates the stock is not yet over sold or over bought based on the technical indicators.
Envision Healthcare Corporation (NYSE:EVHC) has tumbled 4.34% during the past week and has dropped 10.74% in the last 4 week period. The stocks are negative as compared to the S&P 500 for the past week with a loss of 4.57%. Envision Healthcare Corporation (NYSE:EVHC) has underperformed the index by 11.76% in the last 4 weeks. Investors should watch out for further signals and trade with caution.
For the current week, the company shares have a recommendation consensus of Buy. Envision Healthcare Corporation (NYSE:EVHC) stock ended Friday session in the red zone in a volatile trading. The stock closed down 0.42 points or 0.65% at $63.9 with 1,438,652 shares getting traded. Post opening the session at $64.38, the shares hit an intraday low of $63.29 and an intraday high of $64.42 and the price was in this range throughout the day. The company has a market cap of $7,502 million and the number of outstanding shares has been calculated to be 117,406,120 shares. The 52-week high of Envision Healthcare Corporation (NYSE:EVHC) is $83.27 and the 52-week low is $57.32.
Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.Envision Healthcare Holdings Inc was Reiterated by RBC Capital Mkts on Mar 1, 2017 to Outperform, Lowers Price Target to $ 80 from a previous price target of $87 .Company shares were Reiterated by RBC Capital Mkts on Jan 5, 2017 to Outperform, Raises Price Target to $ 87 from a previous price target of $30 .
Company has reported several Insider transactions to the SEC, on Mar 1, 2017, Robert Jon Coward (President Physician Services) sold 1,500 shares at 65.00 per share price.On Mar 17, 2016, Steven G Murphy (SVP of Gov. & Nat. Services) sold 17,021 shares at 20.45 per share price.On Oct 7, 2015, Leonard M Jr Riggs (director) sold 4,000 shares at 36.24 per share price.
Envision Healthcare Holdings Inc Last issued its quarterly earnings results on Feb 28, 2017. The company reported $1.15 EPS for the quarter, missing the analyst consensus estimate by $ -0.07. Analyst had a consensus of $1.22. The company had revenue of $1390.60 million for the quarter, compared to analysts expectations of $1410.13 million. The companys revenue was up 97.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.07 EPS.
Envision Healthcare Corporation provides healthcare services. It offers physician-led services, ambulatory surgery centre management, post-acute care and medical transportation. Envision Healthcare Corporation, formerly known as AMSURG Corp., is based in Nashville, United States.